Obsidian Therapeutics to Participate in the Truist Securities Cell Therapy Symposium

June 28, 2022

Read More

Obsidian Therapeutics to Present at the Jefferies Global Healthcare Conference

June 7, 2022

Read More

Obsidian Therapeutics to Present Significant Advancements to its Proprietary cytoDRiVE® Technology at the American Society of Gene and Cell Therapy (ASGCT) Annual Meeting 2022

May 17, 2022

Read More

We are pioneers in cell and gene therapy

Leading the next generation of engineered therapeutics

Read More

Our Platform

Our proprietary
cytoDRiVE platform

Leverages drug responsive domains (DRDs) to control protein function using an FDA-approved small molecule

Read More


Join Our Team

Join our collaborative team of innovators who are motivated by a sense of urgency to help patients in need.
Our collective knowledge, capabilities, intellect and energy is our greatest strength.


Read More